Related Experiment Video
Updated: Aug 24, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Bradycardia during therapy for multiple myeloma with thalidomide
Ibrahim Elias Fahdi1, Venkat Gaddam, Jorge F Saucedo
1Division of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Abstract:
We studied the medical records of 96 patients who received thalidomide and 104 patients who made up a control group. We found that 53% of patients (52 patients) using thalidomide had a heart rate of <60 beats/min at some point during follow-up and 19% of thalidomide patients (10 patients) developed symptom-related bradycardia. Reducing the thalidomide dose appeared to alleviate symptoms in most patients.
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Therapeutic Drug Monitoring: Affecting Factors
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with bradycardia...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Drug Dosing: Geriatric Patients
Dosage Regimen: Multiple Oral Dosage
